Oragenics, Inc. (OGEN) to Present Oral Care Probiotics Seminar at SupplySide MarketPlace 2013
4/30/2013 7:43:58 AM
More...
|
Oragenics, Inc. (OGEN) Announces Approval of Common Stock Listing on NYSE MKT
4/8/2013 9:40:56 AM
More...
|
Oragenics, Inc. (OGEN)-Intrexon Corporation Collaboration Announces Significant Progress Towards Commercial Production of Lead Lantibiotic MU1140
2/12/2013 9:49:36 AM
More...
|
Griffin Securities Initiates Research Coverage on Oragenics, Inc. (OGEN)
11/28/2012 9:34:39 AM
More...
|
Oragenics, Inc. (OGEN) Announces New Strategic Partnership With Mexico-Based Company, Pharmacos Exakta, S.A. de C.V.
11/14/2012 9:50:22 AM
More...
|
Oragenics, Inc. (OGEN) Announces New Trading Symbol "OGEN" and Trading of Shares on Both the OTCQB and OTCBB
9/25/2012 9:31:43 AM
More...
|
Oragenics, Inc. (ONI) Announces the Completion of Enrollment for its ProBiora3® Clinical Trial at the University of Washington
9/24/2012 9:57:23 AM
More...
|
Oragenics, Inc. (ONI)’ CEO To Present at the Rodman & Renshaw Annual Global Investment Conference
9/10/2012 9:28:18 AM
More...
|
Oragenics, Inc. (ONI) Announces New Strategic Partnership With Central Business USA for South America
8/6/2012 9:56:04 AM
More...
|
Oragenics, Inc. (ONI) Announces Positive Clinical Results for its Proprietary Oral Care Probiotics Product, EvoraKids®
2/23/2012 7:57:20 AM
More...
|
|